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CC BY-NC-ND license (http://creativeAbstract The objective of this study was to assess the clinical outcome of vesicoureteral re-
flux (VUR) after augmentation cystoplasty alone in patients with a hypocompliant neurogenic
bladder. Between January 2009 and December 2014, 29 patients with a hypocompliant bladder
associated with VUR confirmed by videourodynamics (VUD) preoperatively were recruited in
this study. All patients had undergone bladder augmentation with a generous detubularized
segment of bowel at our institution. No effort had been made to correct the existing reflux.
Preoperative assessment included urinalysis, kidney function tests, ultrasonography, and vi-
deourodynamic evaluation. All patients had various degrees of VUR. The status of VUR and
bladder function were studied by VUD. The mean follow-up period was 2.2 years (range 0.5
e5.5 years). The VUD manifested a significant improvement of bladder capacity, diminution
of intravesical pressure, and resolution of reflux after bladder augmentation. After the sur-
gery, 24/29 (83%) no longer had reflux, 3/29 (10%) showed improvement in reflux, and 2/29
(7%) demonstrated no change in reflux. In addition, 16/21 (76%) patients had reflux Grades
I-III; 100% patients with reflux Grades IV and V had complete cessation of reflux. Only one pa-
tient had symptomatic urinary infection after the surgery. Augmentation enterocystoplasty
without ureteral reimplantation is thus effective and adequate for patients with high-
pressure and hypocompliant neurogenic bladder. Therefore, ureteral reimplantation is not
necessary when augmentation enterocystoplasty is recommended for patients with high-
pressure, low-compliant bladder and VUR.
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Vesicoureteral reflux (VUR) occurs in more than 20% of
patients with neurogenic bladder. High detrusor pressure
and reflux are responsible for renal damage and renal
failure. The best treatment option for reflux is to normalize
the detrusor pressure [1]. In this regard, an important
question arises: “How should we normalize the detrusor
pressure?” Our initial attempts to lower the detrusor pres-
sure and protect the upper urinary tract included the
following: clean intermittent catheterization (CIC) and
administration of parasympatholytic drugs or botulinum
toxin injection. When these conservative programs failed to
achieve an adequate bladder volume with lower pressure
during storage, surgical treatment is usually considered [2].
Bladder augmentation with a detubularized intestinal
segment and ureteral reimplantation performed simulta-
neously had been shown to be successful in increasing
bladder capacity and reducing intravesical pressure due to
the final spherical configuration [3]. Nevertheless, a low-
compliant neurogenic bladder is characterized by high-
pressure urine storage and in these cases VUR more
commonly occurs due to increased intravesical pressure
than due to a congenital malformation of the vesicoureteral
junction [4e6]. Theoretically, by eliminating the high
detrusor pressure, the reflux should be improved or
resolved; consequently, the upper tract deterioration
would be postponed or avoided. However, the simultaneous
ureteral reimplantation and bladder augmentation proce-
dure remains controversial. Following the experience of
Nasrallah and Aliabadi [7], in this study, we decided not to
correct VUR surgically in our 29 patients with a poor-
compliant, high-pressure bladder who underwent bladder
augmentation alone.Materials and methods
In this retrospective study, 29 patients with low-compliant
neurogenic bladders underwent augmentation enter-
ocystoplasty alone as their lower urinary tract reconstruc-
tion surgery at our institution between January 2009 and
December 2014. We reviewed 20 male and 9 female pa-
tients with an average follow-up of 2.2 years following the
initial augmentation surgery. The mean age of patients at
the time of surgery was 30.1 years (range 14e58 years). The
etiology of low-compliant bladder dysfunction was as fol-
lows: a history of traumatic spinal cord injury (n Z 22 pa-
tients), a history of myelomeningocele (n Z 5 patients),
and unexplained causes (n Z 2 patients). The video-
urodynamics (VUD) procedure was performed according to
the criteria of the International Continence Society. All
patients received conservative treatments over a period of
6 months before the surgery. All 29 patients received
augmentation enterocystoplasty without antireflux tech-
nique at our institution (Figure 1). The clinical examination
consisted of a targeted neurological examination, ultra-
sound of the bladder and the upper urinary tract, urinaryand blood laboratory studies, and preoperative and post-
operative VUD.
Statistical analysis
All values are presented as mean  standard deviation.
Statistical analysis was performed using the Student t test.
All p values less than 0.01 were considered significant.
Results
The mean follow-up period of the 29 patients was 2.2 years
(range 0.5e5.5 years). All patients had a detrusor leak
point pressure more than 40 cmH2O, decreased bladder
compliance (<10 mL/cmH2O), and refluxing detrusor pres-
sure with an average of 55.3  15.2 cmH2O before the
surgery. All 29 patients had various degrees of reflux, as
demonstrated by VUD during the filling phase, including
Grade I reflux (nZ 3), Grade II (nZ 7), Grade III (nZ 11),
Grade IV (n Z 5), and Grade V (n Z 3), according to the
International Reflux Study Group Classification. To evaluate
the change of the bladder compliance and VUR, post-
operative urodynamic variables were compared with pre-
operative urodynamic variables (Figure 2 and Table 1).
Reflux resolved in 24 patients (83%), downgraded in three
(10%), but persisted in two (7%). In addition, 16/21 (76%)
patients had reflux Grades IeIII; 100% patients with reflux
Grades IV and V had complete cessation of reflux. The VUD
manifested a significant improvement of bladder capacity,
diminution of maximum detrusor pressure, bladder
compliance, and resolution of VUR after augmentation
enterocystoplasty. The mean total bladder capacity
increased from 250.4  127.5 mL to 457.5  37.3 mL
(p < 0.01) and the mean maximal end filling pressure
decreased from 61.4  28.2 cmH2O to 14.5  4.3 cmH2O
(p < 0.01). Twenty-seven patients were managed with CIC,
with a mean interval of 4e6 hours between catheteriza-
tions; most patients did not experience any difficulty during
the procedure, but two elderly female patients experi-
enced occasional difficulty. Two vigorous male patients
emptied their bladders by abdominal straining after sur-
gery. Twenty-six patients reported completely dry bladder,
two had mild incontinence, and one had moderate incon-
tinence. The incontinence occurred in two patients with
mild leakage once a day to once a week, usually at night
when the bladder was either too full or CIC incompletely
emptied the bladder. One patient with moderate leakage
complained of urinary incontinence despite regular CIC six
to eight times a day. This patient was given an anticholin-
ergic drug (solifenacin) after the surgery to control the
incontinence. Only one patient had recurrent febrile uri-
nary tract infection after surgery and this patient was
treated with antibiotics. In four patients, casing slime
obstructed the catheter after the operation, and thus these
patients received bladder irrigation.
All of the patients had normal creatinine levels (range
55e80 mmol/L). Neither anemia nor electrolyte abnormal-
ity was diagnosed. Similarly, cancer and urolithiasis did not
develop in any of the augmented bladders.
Figure 1. The ideograph of surgical technique.
Figure 2. Low-compliant bladder and preoperative and postoperative VUR images. (A) Preoperative VUD showing bilateral VUR in
a patient with neurogenic bladder. (B) Postoperative VUD without VUR. VUDZ videourodynamics; VURZ vesicoureteral reflux.
Table 1 Comparison of preoperative and postoperative
urodynamic data.
Parameter Preoperative Postoperative p
MCBC 250.4  127.5 mL 457.5  37.3 mL <0.01
MDP 61.4  28.2 cmH2O 14.5  4.3 cmH2O <0.01
BC 3.3  3.1 mL/cmH2O 34.2  10.1 mL/
cmH2O
<0.01
VUR 29 (No. Pts.) 2 (No. Pts.) <0.01
BCZ bladder compliance; MCBCZmaximum cystometric
bladder capacity; MDPZ maximum detrusor pressure; No.
Pts.Z number of patients (p < 0.01); VURZ vesicoureteral
reflux.
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Low bladder compliance means an abnormal volume and
pressure relationship, in which there is a high incremental
rise in bladder pressure during the storage phase [8,9].
Renal deterioration and the incidence of VUR have been
unequivocally shown to be related to high intravesical
pressure, which mainly arises from low bladder compliance
in neurogenic bladders cases [10,11]. Some authors believe
that a high intravesical pressure is responsible for VUR in
this type of bladder and VUR should be resolved after the
abnormally high intravesical pressure is eliminated by
bladder augmentation alone, rendering simultaneous ure-
teral reimplantation unnecessary [12,13]. Some authorshave also supported this view because they believe that
reimplantation in a thick, high-pressure, and contracted
bladder is difficult, and may lead to complications such as
ureteral stenosis or aggravated upper tract deterioration
[14]. Based on this report, we decided to perform
augmentation cystoplasty alone, and thus no effort had
been made to correct reflux surgically. In our study, it is
very clear that all patients had significant improvements
after bladder augmentation alone in terms of safe capacity,
compliance, and renal function. Twenty-nine patients were
identified as having reflux before surgery, with 21 in the
low-grade category and eight in the high-grade category.
After cystoplasty, 24/29 patients had complete cessation of
reflux, whereas reflux improved in three and remained
unchanged in two patients. Our findings suggest that anti-
reflux surgery may not be routinely necessary with bladder
augmentation in hypocompliant neurogenic bladders.
In the study by Nasrallah and Aliabadi [7], 14 patients
received augmentation cystoplasty. After adequate evalu-
ation of 13 patients, cessation of reflux was achieved in 12
patients [7]. Krishna and Gough [15] assessed 17 renal units
for the outcome of reflux after clam ileocystoplasty; in
their study, during the mean follow-up period of 3.3 years,
reflux resolved in 11 patients [15]. Our findings are also
consistent with these early studies, which have shown that
augmentation cystoplasty itself, without ureteric reim-
plantation, may resolve or improve reflux in the vast ma-
jority of cases, even when high-grade VUR is present
[12,13]. However, whether ureteral reimplantation should
be simultaneously performed is still being debated. Some
326 H.-C. Zhang et al.researchers hold the view that, no matter what the reasons
are, ureteral reimplantation should be performed simulta-
neously with bladder augmentation when significant reflux
is present [16e18]. Few studies have provided a more
precise cutoff point for determining whether ureteral
reimplantation should be performed. Soygur et al. [19,20]
stated that patients with preoperative VUR should un-
dergo simultaneous correction during bladder augmenta-
tion when there is low pressure on preoperative VUD,
because persistent VUR can induce scarring from febrile
urinary tract infection. We agree that ureteral reimplan-
tation is not necessary in all patients but may be performed
in patients with lower VUR pressure [21,22]. We currently
believe that most of the reflux or incontinence associated
with high intravesical pressure bladder dysfunction will
resolve once detrusor pressures are adequately lowered
[12,13]. However, whether it can be reimplanted still needs
additional investigations with a larger number of patients
with long-term follow-up. Our data also showed that
persistent postoperative VUR was not the main reason for
postoperative recurrent pyelonephritis and renal deterio-
ration. In our study, five patients (17%) had persistent VUR
postoperatively, as demonstrated by VUD. Furthermore,
only one patient had symptomatic urinary infection after
the surgery. Surprisingly, by performing frequent CIC within
the scope of safe bladder volume, most patients will not
suffer recurrent infection postoperatively. Thus, season-
able CIC and safe bladder volume may be more important
than reimplantation for protecting kidneys from damage
due to febrile urinary tract infection.
Conclusion
In low-compliant neurogenic bladder patients with VUR,
bladder augmentation seems to be more important than
reimplantation for offering protection against kidney
damage. Simultaneous reimplantation may be not neces-
sary during bladder augmentation to treat hypocompliant
neurogenic bladders.
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